Cerebral Microembolism in the Critically Ill With Acute Kidney Injury (COMET-AKI)
Cerebral Microembolism in the Critically Ill With Acute Kidney Injury: A Prospective Multi-Center Randomized Controlled Trial Comparing Continuous With Intermittent Renal Replacement Therapy.
Sponsor: Insel Gruppe AG, University Hospital Bern
Terminated
Futility
Other terminated trials from Insel Gruppe AG, University Hospital Bern
- Cerebral Vasospasm · Phase NA · Jan 2026
- Arrhythmia Burden in Patients With Recurrent, Paroxysmal Atrial Fibrillation Despite Durable Pulmonary Vein Isolation · Sep 2025
- Head and Neck Cancer · Phase NA · May 2025
- Bariatric Surgery · Phase PHASE4 · Feb 2025
- Diet, Healthy · Phase NA · Nov 2024
See all terminations from Insel Gruppe AG, University Hospital Bern
A NA clinical study on Cerebral Embolism, this trial is terminated or withdrawn. The trial is conducted by Insel Gruppe AG, University Hospital Bern and has accumulated 13 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jul 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jul 2023 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Oct 2021 — Dec 2022 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Recruiting NA
-
Oct 2019 — Dec 2020 [monthly]
Recruiting NA
-
Sep 2019 — Oct 2019 [monthly]
Recruiting NA
-
Feb 2019 — Sep 2019 [monthly]
Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Insel Gruppe AG, University Hospital Bern
For direct contact, visit the study record on ClinicalTrials.gov .